HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Day 2

SOLACI CACI | TAVI: Evidencia para pacientes de riesgo intermedio

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Oscar...
solaci -
Learn More
DAY 1

SOLACI CACI 2017 | Role of embolic protection during Transcatheter Aortic valve replacement

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Samir...
solaci -
Learn More
DAY 1

SOLACI CACI 2017 | When and how to interving patients with CAD undergoing TAVI

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Fabio...
solaci -
Learn More
DAY 1

SOLACI CACI 2017 | Role of general anesthesia compare to conscious sedation during TAVR

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress.  Check the presentation of Dr....
solaci -
Learn More
Structural heart disease

Dual Antiplatelet in TAVR: Is Single Better?

Courtesy of Dr. Agustín Vecchia. As TAVR is expanded to lower risk patients, complications become more relevant. As regards...
solaci -
Learn More
Structural heart disease

Lotus vs Sapien 3, different mechanisms with similar results

The new generation devices for transfemoral transcatheter aortic valve replacement have been optimized to improve valve position and...
solaci -
Learn More
SOLACI

How can we classify aortic stenosis in patients who underwent TAVR?

Courtesy of Dr. Carlos Fava. Aortic stenosis can present different hemodynamic patterns, such as low flow and low gradient with...
solaci -
Learn More
Structural heart disease

Increasing operator experience improves TAVR outcomes

The introduction of transcatheter aortic valve replacement (TAVR) into clinical practice in the United States has been...
solaci -
Learn More